What Has Been the Growth Trajectory for the Medical Linear Particle Accelerator Market in Recent Years?
The medical linear particle accelerator market has seen considerable growth due to a variety of factors.
• In recent years, the medical linear particle accelerator sector has seen significant growth. The market size is projected to rise from $2.55 billion in 2024 to $2.69 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 5.6%.
This growth during the historic era can be linked to factors such as wider healthcare accessibility, a surge in demand for radiotherapy infrastructure, an increased need for proton therapy, growth in multimodal cancer treatments, and an uptick in the acceptance of robot-assisted surgeries.
What Can Be Expected from the Medical Linear Particle Accelerator Market in the Coming Years?
The medical linear particle accelerator market is expected to maintain its strong growth trajectory in upcoming years.
• Prospects for the medical linear particle accelerator market look bright with robust growth predicted in the next few years. By 2029, the market is anticipated to reach $3.31 billion, indicating a compound annual growth rate (CAGR) of 5.3%.
This increasing trend in the forecast period is linked to the rising demand for customized medication, increased uptake of cost-friendly radiation therapy solutions, a surge in clinical trials, the growing popularity of minimally invasive surgeries and an increase in interest for cancer treatments which are specific and targeted. Technological strides in radiation therapy, telemedicine, and remote radiotherapy planning, the blending of artificial intelligence (AI) and machine learning (ML) technologies, advancements in imaging techniques and the incorporation of digital health technologies into radiotherapy represent the major trends throughout these forecast years.
What Are the Critical Driver Fuelling the Medical Linear Particle Accelerator Market's Growth?
The increase in cancer cases is projected to fuel the expansion of the medical linear particle accelerator market. Cancer is a group of diseases distinguished by the uncontrollable growth and spread of abnormal cells, often producing tumors or affecting other body parts. The increase in cancer cases is due to factors like exposure to environmental contaminants, genetic predisposition, enhanced detection and screening, infections, hormonal elements, and greater awareness. Medical linear particle accelerators (LINACs) contribute to cancer treatment by emitting accurate high-energy radiation to target and eradicate cancer cells, thereby improving the effectiveness of treatment and lessening side effects. As an example, the Australian Institute of Health and Welfare, a government agency in Australia, reported in July 2024 that the number of diagnosed cancer cases in Australia rose from 160,570 in 2022 to 164,694 in 2023, indicating a remarkable increase over the year. Hence, the increasing occurrence of cancer is propelling the expansion of the medical linear particle accelerator market.
How Is the Medical Linear Particle Accelerator Market segmented?
The medical linear particle accelerator market covered in this report is segmented –
1) By Product Type: Dedicated Linear Accelerator, Non-Dedicated Linear Accelerator
2) By Treatment Type: Intensity Modulated Radiation Therapy, Volumetric Modulated Arc Therapy, Image Guided Radiation Therapy, Stereotactic Radiosurgery And Stereotactic Body Radiotherapy
3) By End-User: Hospital, Radiology, Clinics, Other End-Users
Subsegments:
1) By Dedicated Linear Accelerator: Radiation Therapy Linear Accelerators, Medical Linear Accelerators for Cancer Treatment, High-Energy Linear Accelerators
2) By Non-Dedicated Linear Accelerator: General Purpose Linear Accelerators, Laboratory-Grade Non-Dedicated Linear Accelerators, Research And Development Linear Accelerators
Pre-Book The Medical Linear Particle Accelerator Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing the Medical Linear Particle Accelerator Market?
Leading firms in the medical linear particle accelerator industry are prioritizing the development of technologically superior solutions, such as radiotherapy systems, to increase treatment accuracy and better patient prognosis in cancer therapy. Radiotherapy systems constitute medical advancements like linear accelerators, which utilize high-energy radiation to accurately target and eradicate tumors while causing minimal harm to nearby healthy tissue. For instance, Elekta AB, a medical equipment establishment based in Sweden, introduced the Elekta Evo, an AI-supportive adaptive CT-linear accelerator in May 2024, intending to revolutionize cancer treatment. Armed with Iris, an AI-supplemented high-definition imaging system, the Elekta Evo allows medical professionals to see treatment zones with exceptional sharpness, guaranteeing accurate tumor targeting and safeguarding adjacent healthy tissue. Additionally, the device integrates adaptive radiation therapy features, providing for both online and offline alterations to treatment strategies. As a result, it tailors care to match the individual needs of each patient.
Who Are the Key Players in the Medical Linear Particle Accelerator Market?
Major companies operating in the medical linear particle accelerator market are include:
• Mitsubishi Electric Corporation
• Siemens Healthineers AG
• Toshiba Medical Systems Corporation
• GE Healthcare
• Shinva Medical Instrument Co Ltd
• Sumitomo Heavy Industries Ltd
• Neusoft Medical Systems Co Ltd
• Elekta AB
• Varex Imaging Corporation
• Altair Engineering Inc
• Accuray Incorporated
• Brainlab
• Nordion Inc.
• Ion Beam Applications S.A. (IBA)
• Hitachi Medical Corporation
• ViewRay Technologies Inc.
• Laird Thermal Systems Inc.
• Panacea Medical Technologies Pvt Ltd
• RadSource Technologies Inc.
• Xstrahl Limited
• MedicalExpo S.A
• ProTom International Inc.
• ASG superconductors
• Galbino Technology Inc.
• Mevex Corporation
• TibaRay Inc.
What Is The Most Dominant Region In The Medical Linear Particle Accelerator Market?
North America was the largest region in the medical linear particle accelerator market in 2024. The regions covered in the medical linear particle accelerator market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
